Neerav N. Shukla, MD
Pediatric Hematologist-Oncologist & Early Drug Development Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Pediatric Hematology/Oncology
- Pediatric Leukemia and Lymphoma
- Clinical Genomics
About Me
- Chief, Pediatric Translational Medicine Service (PTMS)
- Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chair
I am a pediatric oncologist who specializes in the treatment of children and young adults with leukemia and lymphoma. The MSK Kids team treats these cancers using individualized combinations of drugs tailored to the genetic features of each child’s tumor. Depending on the type of cancer, treatment can take months to years to complete. I am with my patients and their families every step of the way.
I also serve as Service Chief for Memorial Sloan Kettering’s Pediatric Translational Medicine Service. Through this precision medicine program, we analyze the genetic features of every young patient’s cancer to identify mutations or other molecular changes that may be driving the cancer’s growth. We use the results to find the most-effective therapies, customizing treatment for each child’s cancer. This program also has an important research component. Our doctors work with investigators to develop new therapies and conduct clinical trials for all types of pediatric cancer.
Read more
At Memorial Sloan Kettering, patients and their families benefit from the years of expertise shared by our doctors and researchers, and from the high volume of patients we care for, people with every type of childhood cancer. I work as part of a dedicated team that brings together surgeons, radiologists, radiation oncologists, nurses, psychiatrists, social workers, and others with a shared commitment to providing the best possible care for every child.
A pediatric hematologist-oncologist is a doctor who treats cancers of the blood in children and adolescents. This doctor is a hematologist (HEE-muh-TAH-loh-jist) who diagnoses and treats blood disorders. They also are an oncologist (cancer doctor).
An early drug development specialist tests new drugs to treat cancer. They have special training in research studies, known as clinical trials.
My Specialties
- Pediatric Hematology/Oncology
- Pediatric Leukemia and Lymphoma
- Clinical Genomics
Education
- MD, George Washington University
Residencies
- Pediatrics - St. Christopher's Hospital for Children
Fellowships
- Pediatric Hematology/Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Pediatrics
- Pediatric Hematology-Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Shukla sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Shukla
- A Phase I Study of MRX-2843 in Adolescents and Young Adults with Recurrent or Persistent Acute Leukemias
- A Phase III Study Comparing Standard Chemotherapy to Treatment with CPX-351 and/or Gilteritinib for Children Newly Diagnosed with Acute Myeloid Leukemia
- Clinical Trials Co-Investigated by Dr. Shukla
- A Phase 1 Study of Selinexor and Venetoclax with Chemotherapy in Children, Teens, and Young Adults with Acute Leukemia
- A Phase 3 Study of Standard Chemotherapy with or without Venetoclax in Children and Adolescents with Relapsed Acute Myeloid Leukemia
Read more
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Shukla’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Neerav N. Shukla discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].